EDA
The new article provides additional clarifications regarding various specific aspects to be taken into consideration by the parties responsible for clinical investigations intended to be conducted in Egypt.
FDA
The new article outlines the key points regarding patient preference information and its use in the context of the product lifecycle.
CDSCO
The new article outlines the key responsibilities of an investigator in the context of a clinical trial.
CDSCO
The new article addresses the matters related to monitoring to be conducted in the course of a clinical investigation.
CDSCO
The new article goes into further detail regarding the record-keeping requirements, as well as quality assurance in the context of clinical investigations intended to be conducted in India.
CDSCO
The last article from the cycle elaborates on the applicability of the principles and approaches described in the guidance in special cases.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
